July 21st 2021
Findings from an ongoing phase 1 trial were presented at the 2021 ASGCT meeting.
July 19th 2021
Early safety and efficacy data support the use of natural killer T (NKT) cells in patients with stage IV relapsed/refractory neuroblastoma.
July 14th 2021
The CEO of Avamab Pharma discussed how funding and research changes directions.
July 2nd 2021
The CEO of Avamab Pharma discussed how the field of gene therapy has shifted due to the COVID-19 pandemic.
July 1st 2021
The head of neuroscience at Sangamo Therapeutics discussed advances in understanding disease biology that allow for more specific gene targeting.
June 29th 2021
The head of neuroscience at Sangamo Therapeutics discussed the potential of ZFPs in central nervous system disorders.
June 23rd 2021
Flexion Therapeutics believes that local administration of a gene therapy may not only improve pain management but potentially slow disease progression.
May 22nd 2021
Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.
May 13th 2021
No adverse effects on weight, general activity, or survival in knockout mice and wild type littermates were observed throughout the study.